Oberton Karleen Marie
Known title: DirectorCIK: 0001314036
Transaction History
| AME | ▲ Buy | Grant | 950 | $202K | 3/18/2026 | View on chart |
| AME | ▼ Sell | Gift | 1,250 | $0 | 12/30/2025 | View on chart |
| AME | ▲ Buy | Grant | 1,030 | $181K | 3/18/2025 | View on chart |
| AME | ▲ Buy | Grant | 1,030 | $187K | 3/19/2024 | View on chart |
| AME | ▲ Buy | Grant | 1,210 | $168K | 3/22/2023 | View on chart |
| AME | ▲ Buy | Grant | 1,280 | $172K | 3/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AME: Q3 earnings call set, Citigroup target raised, long-term holdings
AMETEK has announced its third-quarter 2026 earnings call details. Citigroup recently maintained its neutral stance while raising its price target to $263. Other reports focus on the stock's long-term performance over the past 15 years and billionaire Mario Gabelli's decade-long holding of the company. The average analyst target is $282.06.
AME: Q3 earnings call set, Citigroup target raised, long-term holdings. AMETEK has announced its third-quarter 2026 earnings call details. Citigroup recently maintained its neutral stance while raising its price target to $263. Other reports focus on the stock's long-term performance over the past 15 years and billionaire Mario Gabelli's decade-long holding of the company. The average analyst target is $282.06.